drugset / Trial / NCT02141620

n-Acetylcysteine and Cocaine

NCT02141620

RandomizedCrossoverTriple-blindBasic science

Summary

This study will determine the initial efficacy, safety and tolerability of n-acetylcysteine as a pharmacotherapy for cocaine dependence. A rigorous, inpatient human laboratory study will be conducted in which the subjective, physiological and reinforcing effects of cocaine are evaluated during maintenance on placebo and n-acetylcysteine.

Timeline

Start
2014-05
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Cocaine Small molecule
Subject N-acetylcysteine Small molecule Oral